| Blood BDNF concentrations reflect brain-tissue BDNF levels across species AB Klein, R Williamson, MA Santini, C Clemmensen, A Ettrup, M Rios, ... International Journal of Neuropsychopharmacology 14 (3), 347-353, 2011 | 815 | 2011 |
| Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014 M Villumsen, S Aznar, B Pakkenberg, T Jess, T Brudek Gut 68 (1), 18-24, 2019 | 295 | 2019 |
| Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data V Trajkovska, AB Marcussen, M Vinberg, P Hartvig, S Aznar, GM Knudsen Brain research bulletin 73 (1-3), 143-149, 2007 | 263 | 2007 |
| The 5-HT1A serotonin receptor is located on calbindin-and parvalbumin-containing neurons in the rat brain S Aznar, Z Qian, R Shah, B Rahbek, GM Knudsen Brain research 959 (1), 58-67, 2003 | 226 | 2003 |
| Aβ (1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels R Christensen, AB Marcussen, G Wörtwein, GM Knudsen, S Aznar Experimental Neurology 210 (1), 164-171, 2008 | 124 | 2008 |
| Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade? S Aznar, GM Knudsen Journal of Alzheimer's Disease 23 (2), 177-193, 2011 | 119 | 2011 |
| Alpha‐synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation C Betzer, LB Lassen, A Olsen, RH Kofoed, L Reimer, E Gregersen, ... EMBO reports 19 (5), e44617, 2018 | 117 | 2018 |
| Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases R Rydbirk, J Folke, K Winge, S Aznar, B Pakkenberg, T Brudek Scientific reports 6 (1), 37116, 2016 | 107 | 2016 |
| Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS HH Hansen, O Waroux, V Seutin, TJ Jentsch, S Aznar, JD Mikkelsen The Journal of physiology 586 (7), 1823-1832, 2008 | 105 | 2008 |
| The 5-HT2A serotonin receptor in executive function: Implications for neuropsychiatric and neurodegenerative diseases S Aznar, MES Hervig Neuroscience & Biobehavioral Reviews 64, 63-82, 2016 | 96 | 2016 |
| Immunodetection of the serotonin transporter protein is a more valid marker for serotonergic fibers than serotonin K Nielsen, D Brask, GM Knudsen, S Aznar Synapse 59 (5), 270-276, 2006 | 95 | 2006 |
| The brain 5‐HT4 receptor binding is down‐regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration CL Licht, AB Marcussen, G Wegener, DH Overstreet, S Aznar, ... Journal of neurochemistry 109 (5), 1363-1374, 2009 | 93 | 2009 |
| Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration M Ziebell, U Khalid, AB Klein, S Aznar, G Thomsen, P Jensen, ... Neurobiology of aging 33 (2), 428. e1-428. e5, 2012 | 78 | 2012 |
| Ultra-fast label-free quantification and comprehensive proteome coverage with narrow-window data-independent acquisition UH Guzman, A Martinez-Val, Z Ye, E Damoc, TN Arrey, A Pashkova, ... Nature biotechnology, 1-12, 2024 | 71 | 2024 |
| 5-HT2A and mGlu2 receptor binding levels are related to differences in impulsive behavior in the Roman Low-(RLA) and High-(RHA) avoidance rat strains AB Klein, L Ultved, D Adamsen, MA Santini, A Tobeña, ... Neuroscience 263, 36-45, 2014 | 70 | 2014 |
| Regulating Prefrontal Cortex Activation: An Emerging Role for the 5-HT2A Serotonin Receptor in the Modulation of Emotion-Based Actions? S Aznar, AB Klein Molecular neurobiology 48, 841-853, 2013 | 68 | 2013 |
| Cytokine profiling in the prefrontal cortex of Parkinson's disease and multiple system atrophy patients R Rydbirk, B Elfving, MD Andersen, MA Langbøl, J Folke, K Winge, ... Neurobiology of Disease 106, 269-278, 2017 | 62 | 2017 |
| Changes in 5-HT2A-mediated behavior and 5-HT2A-and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice AB Klein, MA Santini, S Aznar, GM Knudsen, M Rios Neuroscience 169 (3), 1007-1016, 2010 | 59 | 2010 |
| Non-serotonergic dorsal and median raphe projection onto parvalbumin-and calbindin-containing neurons in hippocampus and septum S Aznar, ZX Qian, GM Knudsen Neuroscience 124 (3), 573-581, 2004 | 59 | 2004 |
| PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia J Magalhaes, E Tresse, P Ejlerskov, E Hu, Y Liu, A Marin, A Montalant, ... Molecular psychiatry 26 (10), 6083-6099, 2021 | 49 | 2021 |
